KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCash from Discontinued OperationsCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Change in Cash: 2010-2025

Historic Change in Cash for TherapeuticsMD (TXMD) over the last 15 years, with Sep 2025 value amounting to $1.0 million.

  • TherapeuticsMD's Change in Cash rose 665.41% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year increase of 140.40%. This contributed to the annual value of $732,000 for FY2024, which is 101.63% up from last year.
  • As of Q3 2025, TherapeuticsMD's Change in Cash stood at $1.0 million, which was up 222.84% from $324,000 recorded in Q2 2025.
  • TherapeuticsMD's 5-year Change in Cash high stood at $57.1 million for Q1 2021, and its period low was -$39.7 million during Q4 2021.
  • Moreover, its 3-year median value for Change in Cash was $11,000 (2024), whereas its average is -$3.8 million.
  • In the last 5 years, TherapeuticsMD's Change in Cash slumped by 4,761.85% in 2021 and then skyrocketed by 6,136.36% in 2025.
  • TherapeuticsMD's Change in Cash (Quarterly) stood at -$39.7 million in 2021, then soared by 127.66% to $11.0 million in 2022, then crashed by 153.14% to -$5.8 million in 2023, then spiked by 100.21% to $12,000 in 2024, then soared by 665.41% to $1.0 million in 2025.
  • Its Change in Cash stands at $1.0 million for Q3 2025, versus $324,000 for Q2 2025 and $686,000 for Q1 2025.